Tal Zvi Zaks, Chief Medical Officer at Moderna, Inc. (MRNA), sold 17,800 shares at $157.29 ($2.7M) on 2021-03-01, disclosed to the SEC on 2021-03-02.
Open-market sale of $2.7M MRNA by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $146.68 | 2,201 | $323K | 12.1% |
| 2 | $146.68 | 2,201 | $323K | 12.1% |
| 3 | $147.71 | 1,986 | $293K | 11.0% |
| 4 | $147.71 | 1,986 | $293K | 11.0% |
| 5 | $149.00 | 700 | $104K | 3.9% |
| 6 | $149.79 | 1,039 |
| $156K |
| 5.8% |
| 7 | $149.79 | 1,039 | $156K | 5.8% |
| 8 | $150.86 | 600 | $91K | 3.4% |
| 9 | $150.86 | 600 | $91K | 3.4% |
| 10 | $152.01 | 900 | $137K | 5.1% |
| 11 | $154.34 | 753 | $116K | 4.3% |
| 12 | $154.34 | 753 | $116K | 4.3% |
| 13 | $155.69 | 600 | $93K | 3.5% |
| 14 | $156.49 | 771 | $121K | 4.5% |
| 15 | $156.49 | 771 | $121K | 4.5% |
| 16 | $157.29 | 450 | $71K | 2.6% |
| 17 | $157.29 | 450 | $71K | 2.6% |
| Total | $150.25 avg | 17,800 | $2.7M | 100% |
| Filing → |
| MRNA | SELL | 2021-06-25 | $1.1M | — | Filing → |
| MRNA | SELL | 2021-06-21 | $1.0M | — | Filing → |
| MRNA | SELL | 2021-06-11 | $1.1M | — | Filing → |